Aarti Pharmalabs Ltd

543748

Summary

Fair Value Assessment
Fairly Valued
Fair ValueQ754.29UncertaintyHigh
Close Price732.50Mar 26, 2025
729.10
Price Down by 3.40 | 0.46 %
Previous Close
732.50
Day Range
715.20 – 732.00
Year Range
429.50 – 837.00
Bid / Ask
728.20 × 729.1
Market Cap
66.2 Bil
Volume / Average
10.5 k / 46.7 k
Beta
Shares Outstanding
90.63 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Aarti Pharmalabs Ltd manufactures pharmaceuticals and nutraceuticals with a footprint. It manufactures Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, and xanthine derivatives in India. It also offers Contract Development and Manufacturing Services (CDMS) for drug substance (NCE, RSM, Intermediates) projects. Geographically, the company generates maximum revenue from its customers located outside India.
Contact
Mulund Goregaon Link Road 2nd floor, 204, Udyog Kshetra, Mumbai, MH 400080
T +91 2269436100
www.aartipharmalabs.com opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Dec 31, 2024
Fiscal Year End
Mar 31, 2025
Employees
3,183

Key Metrics

Income Statement (in Bil, except ratios)
12/31/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Revenue
20.20 18.16 19.36 11.92
Revenue Growth %
10.82% -6.22% 62.41%
Gross Profit
8.24 7.01 5.31 3.12
Gross Profit Margin %
40.77% 38.59% 27.40% 26.20%
Operating Income
3.53 3.13 2.81 1.65
Operating Margin %
17.48% 17.23% 14.52% 13.86%
EBIT
3.64 3.15 2.79 1.56
EBIT Margin %
18.01% 17.33% 14.44% 13.06%
EBITDA
4.47 3.88 3.42 1.98
EBITDA Margin %
22.13% 21.37% 17.67% 16.60%
Net Income
2.49 2.17 1.93 1.22
Net Profit Margin %
12.34% 11.95% 9.99% 10.26%
Basic EPS
27.51 23.93 21.35 13.49
Diluted EPS
27.50 23.93 21.35 13.49
Normalized EPS
27.36 23.56 21.73
Total Dividends per Share
3.00 2.00
Balance Sheet (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Total Assets
27,765.12 25,821.05 22,309.27 20,399.01 2.50
Total Liabilities
9,197.85 8,250.66 6,724.41 6,534.22 0.22
Total Debt
3,864.70 2,852.54 2,153.13 3,414.01 0.17
Total Equity
18,567.27 17,570.39 15,584.87 13,864.80 2.28
Cash And Cash Equivalents
408.08 236.35 249.30 832.73 2.50
Working Capital
6,931.86 6,512.52 5,641.94 4,474.84 2.28
Shares Outstanding (Bil)
90.63 90.63
Book Value Per Share
193.85 171.97
Total Debt To Equity
0.21 0.16 0.14 0.25 0.08
Cash Flow Statement (in Bil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
2.11 2.16 2.63 -0.44
Cash From Investing Activities
-2.92 -2.15 -1.58 -1.39
Cash From Financing Activities
1.10 0.10 -1.63 2.60
Capital Expenditures
1.99 1.20 1.41
Free Cash Flow
1.22 1.40 0.34
Change in Cash
0.29 0.12 -0.58 0.78

Profile

Name (Age)
5-Year Trend
2021
2022
2023
2024
2025
Hetal Gogri Gala (—) Vice Chairman of the Board and Managing Director
Narendra Jagannath Salvi (—) Director and Managing Director
Total Compensation for all Key Executives
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership

Name
% Total
Shares Held
% Total
Assets
Trend
Prev. 8 Qtrs
Change Amount
Change %
Date
MS INVF Emerging Leaders Equity A 1.00 0.82 909,590
Dec 31, 2024
iShares Core MSCI Emerging Markets ETF 0.62 0.01 565,554
666
0.12%
Feb 28, 2025
HDFC Multi Cap Reg Gr 0.47 0.21 428,834
Feb 28, 2025
DFA Emerging Markets Core Equity I 0.25 0.01 222,936
12,547
5.96%
Jan 31, 2025
Morgan Stanley Inst EMkts Ldrs I 0.22 0.85 202,698
-24,131
10.64%
Dec 31, 2024
Total (for Top 5) 2.57 2,329,612
-10,918

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top